A critical advance in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This essential cancer inhibitor protein is frequently lost in many kinds of cancer, causing uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research